DRKS00000240尚未招募未知
ong-term performance and survival rate of press veneered zirconia and monolithic CAD/CAM lithium disilicate crowns: A prospective randomized clinical splitmouth study over 5 years
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- All
入选标准
- •Two comparable, teeth (molars) in need of a crown restoration, good oral hygiene, healthy periodontal condition, healthy endodontical condition
排除标准
- •Teeth are not in need of a crown restoration
研究者
相似试验
已完成
不适用
ong-term stability and survival rates of a novel Oticon Medical bone conduction device implantimplant stabilitylocal skin reactions100192431004078510019190NL-OMON37464Oticon Medical AB60
招募中
Unknown
ongterm survival rate and possible complications of narrow diameter Implants PF 3.0 in the aesthetic areanarrow diameter implants in the esthetic zoneDRKS00032708Klinik und Poliklinik für Mund-, Kiefer- und Gesichtschirugie-plastische Operationen30
进行中（未招募）
1 期
Evaluating the Long-Term Outcomes and Durability of Effect Following Treatment with Cladribine Tablets for Multiple Sclerosis: An Exploratory Phase IV Ambispective Study of Patients Who Previously Participated in the CLARITY/CLARITY-EXT and ORACLE MS Clinical TrialsMedDRA version: 20.0Level: SOCClassification code 10029205Term: Nervous system disordersSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.1Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersMultiple SclerosisEUCTR2019-000069-19-SEMerck KGaA1,000
进行中（未招募）
1 期
Evaluating the Long-Term Outcomes and Durability of Effect Following Treatment with Cladribine Tablets for Multiple Sclerosis: An Exploratory Phase IV Ambispective Study of Patients Who Previously Participated in the CLARITY/CLARITY-EXT and ORACLE MS Clinical TrialsMedDRA version: 20.0Level: SOCClassification code 10029205Term: Nervous system disordersSystem Organ Class: 10029205 - Nervous system disordersMultiple SclerosisMedDRA version: 20.1Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2019-000069-19-EEMerck KGaA1,000
进行中（未招募）
1 期
Evaluating the Long-Term Outcomes and Durability of Effect Following Treatment with Cladribine Tablets for Multiple Sclerosis: An Exploratory Phase IV Ambispective Study of Patients Who Previously Participated in the CLARITY/CLARITY-EXT and ORACLE MS Clinical TrialsMultiple SclerosisEUCTR2019-000069-19-LTMerck KGaA1,000